ANGIODYNAMICS INC (ANGO) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US03475V1017

Price
12.35 USD
Market cap
512.84 m USD
P/E (2026)
–
P/S (2026)
1.60
Dividend yield
0.00 %
Net margin
-11.48 %
Return on equity (ROE)
-21.51 %
Return on assets (ROA)
-13.75 %

ANGIODYNAMICS INC financials

Fiscal year20252026
Revenue292.50 m USD320.17 m USD
Gross profit157.71 m USD174.89 m USD
Operating income-39.95 m USD-39.93 m USD
EBIT-34.03 m USD-36.30 m USD
Net income-33.99 m USD-36.74 m USD
Diluted EPS – continuing operations-0.83 USD-0.88 USD

Full history since 2001, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About ANGIODYNAMICS INC

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which include angiographic catheters, guidewires, drainage catheters, and micropuncture kits for use in invasive procedures. In addition, the company provides total abscession drainage catheters for multi-purpose/general and biliary configurations, and nephrostomy options; mini stick MAX Coaxial microintroducer kits and micro-introducer kits; ports; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.